Cisplatin, Epirubicin, and Ifosfamide versus Cisplatin, Epirubicin, and Cyclophosphamide in Clear Cell Carcinoma of the Ovary

Saved in:

Bibliographic Details
Published in:	Gynecologic oncology Vol. 67; no. 2; p. 230
Main Authors:	Nishida, Takashi, Sugiyama, Toru, Yakushiji, Michaiki
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-11-1997
Subjects:	Adenocarcinoma, Clear Cell - drug therapy Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cisplatin - administration & dosage Cyclophosphamide - administration & dosage Epirubicin - administration & dosage Female Humans Ifosfamide - administration & dosage Ovarian Neoplasms - drug therapy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Author	Sugiyama, Toru Nishida, Takashi Yakushiji, Michaiki
Author_xml	– sequence: 1 givenname: Takashi surname: Nishida fullname: Nishida, Takashi – sequence: 2 givenname: Toru surname: Sugiyama fullname: Sugiyama, Toru – sequence: 3 givenname: Michaiki surname: Yakushiji fullname: Yakushiji, Michaiki
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/9367714$$D View this record in MEDLINE/PubMed
BookMark	eNp9kE9PwzAMxSM0NLbBlRtSPgAd7r80OaJqwKRJO8C9ShOXBbVNlXSTduC706oTNzjZ8nvPtn5LMmtti4Tch7AOAdjT57m161CIbJ1wJq7IIgSRBoynYkYWAAICHqX8hiy9_wKAGMJoTuYiZlkWJgvynRvf1bI37SPddMYdS6PGXraabivrK9kYjfSEzh89_cecn1Vtu4P13WGKmJbmNUpHc6xrmks3WG0jqa1of0C6P0l3viXXlaw93l3qiry_bD7yt2C3f93mz7tAJXHSBwojpqDiqFFxoYFHEU8zEVVlwiSUUGasSpiKMUmZHiik4yhOESHMBItXZD1tVc5677AqOmea4XwRQjFCLEaIxQixGCEOgYcp0B3LBvWv_UJt0Pmk4_DzyaArvDLYKtTGoeoLbc1fq38AhbWELw
CitedBy_id	crossref_primary_10_1002_pbc_26457
Cites_doi	10.1016/0090-8258(84)90222-1 10.1006/gyno.1993.1117 10.1056/NEJM199004123221501
ContentType	Journal Article
Copyright	1997 Academic Press
Copyright_xml	– notice: 1997 Academic Press
DBID	CGR CUY CVF ECM EIF NPM AAYXX CITATION
DOI	10.1006/gyno.1997.4869
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef
Database_xml	– sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1095-6859
EndPage	230
ExternalDocumentID	10_1006_gyno_1997_4869 9367714 S0090825897948691
Genre	Letter Clinical Trial Randomized Controlled Trial
GroupedDBID	--- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29I 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AAXUO ABBQC ABFNM ABFRF ABJNI ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADFGL ADMUD AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFFNX AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DU5 EBS EFBJH EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IH2 IHE J1W K-O KOM L7B LCYCR LG5 M29 M41 MO0 N9A O-L O9- OAUVE OQ. OZT P-8 P-9 P2P PC. PH~ Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SES SEW SPCBC SSH SSZ T5K UDS UHS UV1 WUQ X7M XPP Z5R ZGI ZMT ZU3 ZXP ~G- AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION
ID	FETCH-LOGICAL-c434t-ce26c0f8edec89d082285792fb46a0b0b76f46c3e456d8695b0b735ee017963
ISSN	0090-8258
IngestDate	Thu Sep 26 18:59:08 EDT 2024 Sat Sep 28 07:33:38 EDT 2024 Fri Feb 23 02:29:43 EST 2024
IsPeerReviewed	true
IsScholarly	true
Issue	2
Language	English
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c434t-ce26c0f8edec89d082285792fb46a0b0b76f46c3e456d8695b0b735ee017963
PMID	9367714
PageCount	1
ParticipantIDs	crossref_primary_10_1006_gyno_1997_4869 pubmed_primary_9367714 elsevier_sciencedirect_doi_10_1006_gyno_1997_4869
PublicationCentury	1900
PublicationDate	1997-11-01
PublicationDateYYYYMMDD	1997-11-01
PublicationDate_xml	– month: 11 year: 1997 text: 1997-11-01 day: 01
PublicationDecade	1990
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Gynecologic oncology
PublicationTitleAlternate	Gynecol Oncol
PublicationYear	1997
Publisher	Elsevier Inc
Publisher_xml	– name: Elsevier Inc
References	Guthrie, Davy, Philips (GO974869C1) 1984; 17 Young, Walton, Ellenberg (GO974869C4) 1990; 322 O’Brien, Schofield, Tan, Fryatt, Fisher, Wiltshaw (GO974869C2) 1993; 49 Teufel, Pfeiderer (GO974869C3) 1976; 36 Teufel (10.1006/gyno.1997.4869_GO974869C3) 1976; 36 Young (10.1006/gyno.1997.4869_GO974869C4) 1990; 322 O’Brien (10.1006/gyno.1997.4869_GO974869C2) 1993; 49 Guthrie (10.1006/gyno.1997.4869_GO974869C1) 1984; 17
References_xml	– volume: 322 start-page: 1021 year: 1990 end-page: 1027 ident: GO974869C4 article-title: Adjuvant therapy in stage I and II epithelial ovarian cancer: results of two prospective randomized trials publication-title: N Engl J Med contributor: fullname: Ellenberg – volume: 36 start-page: 274 year: 1976 end-page: 279 ident: GO974869C3 article-title: Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinoma publication-title: Geburts Frauenheilk contributor: fullname: Pfeiderer – volume: 49 start-page: 250 year: 1993 end-page: 254 ident: GO974869C2 article-title: Clear cell epithelial cancer (mesonephroid): bad prognosis only early stage disease publication-title: Gynecol Oncol contributor: fullname: Wiltshaw – volume: 17 start-page: 363 year: 1984 end-page: 369 ident: GO974869C1 article-title: A study of 656 patients with “early” ovarian cancer publication-title: Gynecol Oncol contributor: fullname: Philips – volume: 36 start-page: 274 year: 1976 ident: 10.1006/gyno.1997.4869_GO974869C3 article-title: Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinoma publication-title: Geburts Frauenheilk contributor: fullname: Teufel – volume: 17 start-page: 363 year: 1984 ident: 10.1006/gyno.1997.4869_GO974869C1 article-title: A study of 656 patients with “early” ovarian cancer publication-title: Gynecol Oncol doi: 10.1016/0090-8258(84)90222-1 contributor: fullname: Guthrie – volume: 49 start-page: 250 year: 1993 ident: 10.1006/gyno.1997.4869_GO974869C2 article-title: Clear cell epithelial cancer (mesonephroid): bad prognosis only early stage disease publication-title: Gynecol Oncol doi: 10.1006/gyno.1993.1117 contributor: fullname: O’Brien – volume: 322 start-page: 1021 year: 1990 ident: 10.1006/gyno.1997.4869_GO974869C4 article-title: Adjuvant therapy in stage I and II epithelial ovarian cancer: results of two prospective randomized trials publication-title: N Engl J Med doi: 10.1056/NEJM199004123221501 contributor: fullname: Young
SSID	ssj0003012
Score	1.5760775
SourceID	crossref pubmed elsevier
SourceType	Aggregation Database Index Database Publisher
StartPage	230
SubjectTerms	Adenocarcinoma, Clear Cell - drug therapy Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cisplatin - administration & dosage Cyclophosphamide - administration & dosage Epirubicin - administration & dosage Female Humans Ifosfamide - administration & dosage Ovarian Neoplasms - drug therapy
Title	Cisplatin, Epirubicin, and Ifosfamide versus Cisplatin, Epirubicin, and Cyclophosphamide in Clear Cell Carcinoma of the Ovary
URI	https://dx.doi.org/10.1006/gyno.1997.4869 https://www.ncbi.nlm.nih.gov/pubmed/9367714
Volume	67
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaWVkJcEK-K8pIPSBy2KXk4TnKswgJFohx2D71FjuO06dIk2jSV9tD_zkzsJLtFUEDiEu16bcea-XY8Hs-DkLdMuYILllkpqJ8Wy7htidxzLBF5uQyiLPSjrojtPDg5DT_M2Gwy6Us_jW3_ldPQBrzGyNm_4PYwKTTAZ-A5PIHr8PwjvsdFU6N_m7ar1MWqTfHyvPfSPM6rBo0amZqiQ0bbTO8YEK_l96o-r5r6XA_DMEGsNTGN0ewXYy2isroUvbPBt2uxHWX9aV0qqUXstCrllhn_BC1gWae_LsQS6zqNl1RnxVpc6p-qVTtIJ7FsodtFMfj8F8tiNF10aV-dLdPFEFOz5fIJSh8Gt-uE7odKi2VQBC0emtzhRm7rMh4Gn-6mEDY3PWrz209bBYgb4OXZuqwwYjM4ZKGuGXMr_fYc14PLiUByQRc4ae-6INRApu4eHc9Ovwz7PohKnZverL9PEWrz99tvuUMF2tBvFo_IQ3MwoUcaUY_JRJVPyP2vxvXiKbkZcHJAR5QcUMAIHUFFNajobzrfBhQtStoBiiKg6AAoWuUUAEU7QD0j84-zRfzZMrU7LMk8dmVJ5XJp56HKlAyjDOsKhH4QuXnKuLBTOw14zrj0FCjwGdDExybPVwp3CO7tkZ2yKtVzQh0Z-FGYwSlBSRgA6q3Lcjfw04g5NlPhPnnXEzOpdYKWRKfi5gmSPUGyJ0j2feL0tE6MeqnVxgQg8csxe5opw9yRx4PAYS_-YbKX5MH4L3hFdq5WrXpN7jVZ-8Zg6Qc74qSk
link.rule.ids	315,782,786,27933,27934
linkProvider	Elsevier
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cisplatin%2C+Epirubicin%2C+and+Ifosfamide+versus+Cisplatin%2C+Epirubicin%2C+and+Cyclophosphamide+in+Clear+Cell+Carcinoma+of+the+Ovary&rft.jtitle=Gynecologic+oncology&rft.au=Nishida%2C+Takashi&rft.au=Sugiyama%2C+Toru&rft.au=Yakushiji%2C+Michaiki&rft.date=1997-11-01&rft.pub=Elsevier+Inc&rft.issn=0090-8258&rft.eissn=1095-6859&rft.volume=67&rft.issue=2&rft.spage=230&rft.epage=230&rft_id=info:doi/10.1006%2Fgyno.1997.4869&rft.externalDocID=S0090825897948691
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0090-8258&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0090-8258&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0090-8258&client=summon